Evidence map›Paper›PMID 25637609›Full record

ReviewAmerican journal of physiology. Lung cellular and molecular physiology2015

Pulmonary epithelial barrier function: some new players and mechanisms.

Kieran Brune, James Frank, Andreas Schwingshackl, James Finigan, Venkataramana K Sidhaye

Abstract readReview
In one paragraph

Review in American journal of physiology. Lung cellular and molecular physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 191 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. In vitro approaches to assess respiratory toxicity from volatile organic compounds: an in-depth review.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Review
  4. Article
  5. Article
  6. Beyond the epithelium: multicellular niches in lung regeneration and disease.American journal of physiology. Lung cellular and molecular physiology · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Oral administration of Lactobacillus delbrueckii UFV-H2b20 protects mice against Aspergillus fumigatus lung infection.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  16. Aging-Associated Molecular Changes in Human Alveolar Type I Cells.Journal of respiratory biology and translational medicine · 2024
    Article
  17. Article
  18. A therapy for suppressing canonical and noncanonical SARS-CoV-2 viral entry and an intrinsic intrapulmonary inflammatory response.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  19. Review
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Kieran BruneDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland;
James FrankThe Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco VA Medical Center, and NCIRE/Veterans Health Research Institute, San Francisco, California;
Andreas SchwingshacklDepartment of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee;
James FiniganDivision of Oncology, Cancer Center, National Jewish Health, Denver, Colorado.
Venkataramana K SidhayeDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland; vsidhay1@jhmi.edu.
Johns Hopkins University · USNational Jewish Health · USUniversity of California, San Francisco · USUniversity of Tennessee Health Science Center · US

Funding

Actin-myosin contractility promotes the development of chronic bronchitisR01HL124099 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SIDHAYE, VENKATARAMANA K · 2017 to 2021
$2.1M
ADAM17-NRG-1 Signaling in Acute Lung InjuryR01HL111674 · NHLBI · NATIONAL JEWISH HEALTH · PI FINIGAN, JAMES H · 2012 to 2016
$1.9M
The Role of 2-Pore Domain Potassium Channels in Acute Lung Injury.K08HL118118 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SCHWINGSHACKL, ANDREAS · 2014 to 2018
$792k
Claudin-18 deficiency in the pathogenesis of asthmaR21HL111707 · NHLBI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI FRANK, JAMES A · 2012 to 2013
$399k
Regulation of alveolar barrier function by claudinsR56HL088440 · NHLBI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI FRANK, JAMES A · 2013 to 2013
$380k
NHLBI NIH HHS K08 HL118118NHLBI NIH HHS R01 HL111674NHLBI NIH HHS R01 HL124099NHLBI NIH HHS R21 HL111707NHLBI NIH HHS R56 HL088440
6 · The paper itself

Abstract

The pulmonary epithelium serves as a barrier to prevent access of the inspired luminal contents to the subepithelium. In addition, the epithelium dictates the initial responses of the lung to both infectious and noninfectious stimuli. One mechanism by which the epithelium does this is by coordinating transport of diffusible molecules across the epithelial barrier, both through the cell and between cells. In this review, we will discuss a few emerging paradigms of permeability changes through altered ion transport and paracellular regulation by which the epithelium gates its response to potentially detrimental luminal stimuli. This review is a summary of talks presented during a symposium in Experimental Biology geared toward novel and less recognized methods of epithelial barrier regulation. First, we will discuss mechanisms of dynamic regulation of cell-cell contacts in the context of repetitive exposure to inhaled infectious and noninfectious insults. In the second section, we will briefly discuss mechanisms of transcellular ion homeostasis specifically focused on the role of claudins and paracellular ion-channel regulation in chronic barrier dysfunction. In the next section, we will address transcellular ion transport and highlight the role of Trek-1 in epithelial responses to lung injury. In the final section, we will outline the role of epithelial growth receptor in barrier regulation in baseline, acute lung injury, and airway disease. We will then end with a summary of mechanisms of epithelial control as well as discuss emerging paradigms of the epithelium role in shifting between a structural element that maintains tight cell-cell adhesion to a cell that initiates and participates in immune responses.

Indexed as

AnimalsBiological TransportEpitheliumHumansLungPermeabilityPulmonary AlveoliRespiratory MucosaTight Junctionsepithelial barrierionslungpermeabilitytransport

Identifiers

PMID25637609
PMCPMC4747906
OpenAlexW2089890078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.